Puma Biotechnology PBYI
NASDAQ PBYI
$9.55 +0.14 (+1.49%)
As of: Sep 4, 2026 · 3:59 PM EDT

Puma Biotechnology (PBYI) Property, Plant & Equipment (Net) (2011 - 2026)

Analysis

Puma Biotechnology (PBYI) Property, Plant & Equipment (Net) (2011 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Property, Plant & Equipment (Net) (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 1.67 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 5.46 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 1.96 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 2.06 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 34.61 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 1.64 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 554.14 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 107.22 Mn
10 Puma Biotechnology 486.99 Mn 393.08 Mn 44.03 Mn 103,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 103,000.00
Mar 31, 2026 124,000.00
Dec 31, 2025 187,000.00
Sep 30, 2025 305,000.00
Jun 30, 2025 388,000.00
Mar 31, 2025 474,000.00
Dec 31, 2024 515,000.00
Sep 30, 2024 601,000.00
Jun 30, 2024 680,000.00
Mar 31, 2024 757,000.00
Dec 31, 2023 855,000.00
Sep 30, 2023 907,000.00
Jun 30, 2023 977,000.00
Mar 31, 2023 1.02 Mn
Dec 31, 2022 1.15 Mn
Sep 30, 2022 1.28 Mn
Jun 30, 2022 1.44 Mn
Mar 31, 2022 1.59 Mn
Dec 31, 2021 1.76 Mn
Sep 30, 2021 1.92 Mn